Why the study?
Does the PlA2 polymorphism of the glycoprotein IIIa gene increase the risk of coronary stenosis?
Does the PlA2 polymorphism of the glycoprotein IIIa gene increase the risk of coronary stenosis?
Answers are grounded in this paper and cite their sources.
The PlA2 polymorphism of the platelet glycoprotein IIIa gene is significantly associated with documented coronary stenosis, particularly in patients under 60 years of age.
Based on genetic variability, structural differences in the glycoprotein IIb/IIIa platelet receptor for adhesive proteins result in individual differences in the thrombogenicity of platelets. Recent studies suggest a controversial association between a genetic polymorphism of the glycoprotein IIIa gene (PlA2) and the risk of coronary artery disease. In our study, the prevalence of the PlA2 allele in a group of patients undergoing percutaneous coronary revascularization was 37%, a value significantly higher than in controls [13%, odds ratio (OR) = 3.93, 95% CI, 1.84 to 8.53] suggesting a significant association between this polymorphism and documented coronary stenosis, which is strongest among <60 years old patients (OR = 12.30, 95% CI, 2.98 to 70.93). This polymorphism represents an inherited risk factor for severe cardiovascular disease due to coronary occlusion.
No takes yet. Share an insight, caveat, or question.
A 1998 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: